Resectability of Pancreatic Cancer Is in the Eye of the Observer by Fabio Giannone, MD, Giovanni Capretti, MD, Mohammed Abu Hilal, MD, PhD, Ugo Boggi, MD, Donata Campra, MD, Carla Cappelli, MD, Riccardo Casadei, MD, Raffaele De Luca, MD, Massimo Falconi, MD, Gabriele Giannotti, MD, Luca Gianotti, MD, Roberto Girelli, MD, Paola Gollini, MD, Davide Ippolito, MD, Giorgio Limerutti, MD, Lorenzo Maganuco, MD, Valeria Malagnino, MD, Giuseppe Malleo, MD, PhD, Mario Morone, MD, Cristina Mosconi, MD, Federica Mrakic, MD, Diego Palumbo, MD, Roberto Salvia, MD, PhD, Salvatore Sgroi, MD, Alessandro Zerbi, MD, Gianpaolo Balzano, MD

Get full text

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial by Garassino, Marina Chiara, MD, Martelli, Olga, MD, Broggini, Massimo, PhD, Farina, Gabriella, MD, Veronese, Silvio, PhD, Rulli, Eliana, PhD, Bianchi, Filippo, MD, Bettini, Anna, MD, Longo, Flavia, MD, Moscetti, Luca, MD, Tomirotti, Maurizio, MD, Marabese, Mirko, PhD, Ganzinelli, Monica, PhD, Lauricella, Calogero, PhD, Labianca, Roberto, MD, Floriani, Irene, PhD, Giaccone, Giuseppe, MD, Torri, Valter, MD, Scanni, Alberto, MD, Marsoni, Silvia, MD

Get full text

Oxidative damage and erythrocyte membrane transport abnormalities in thalassemias by OLIVIERI, O, DE FRANCESCHI, L, CAPELLINI, M. D, GIRELLI, D, CORROCHER, R, BRUGNARA, C

Get full text